19 Aug 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Boehringer Ingelheim Chemicals is going to close its Petersburg plant at the end of 2014. The facility will continue normal operations through the remainder of 2013 and phase out operations the following year.
The closure will impact 240 employees through a multi-stage process starting in December 2013. The company announced that it will be offering out-placement services and will reach out to industry partners to explore other opportunities for employees.
The Petersburg facility manufactures active ingredients for the pharmaceutical industry.
Boehringer Ingelheim Chemicals explored selling the facility but was unable to find a suitable buyer.